PL3860582T3 - Związki do zastosowania w leczeniu albo profilaktyce bólu, stanu zapalnego i/lub stanu autozapalnego - Google Patents
Związki do zastosowania w leczeniu albo profilaktyce bólu, stanu zapalnego i/lub stanu autozapalnegoInfo
- Publication number
- PL3860582T3 PL3860582T3 PL20703152.7T PL20703152T PL3860582T3 PL 3860582 T3 PL3860582 T3 PL 3860582T3 PL 20703152 T PL20703152 T PL 20703152T PL 3860582 T3 PL3860582 T3 PL 3860582T3
- Authority
- PL
- Poland
- Prior art keywords
- autoimmunity
- prophylaxis
- inflammation
- pain
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19153315 | 2019-01-23 | ||
PCT/EP2020/051528 WO2020152226A1 (en) | 2019-01-23 | 2020-01-22 | Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3860582T3 true PL3860582T3 (pl) | 2022-08-01 |
Family
ID=65228356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20703152.7T PL3860582T3 (pl) | 2019-01-23 | 2020-01-22 | Związki do zastosowania w leczeniu albo profilaktyce bólu, stanu zapalnego i/lub stanu autozapalnego |
Country Status (17)
Country | Link |
---|---|
US (1) | US11891350B2 (pl) |
EP (1) | EP3860582B1 (pl) |
JP (1) | JP2022518288A (pl) |
KR (1) | KR20210119403A (pl) |
CN (1) | CN113329746A (pl) |
AU (1) | AU2020210831A1 (pl) |
BR (1) | BR112021019476A2 (pl) |
CA (1) | CA3118996A1 (pl) |
DK (1) | DK3860582T3 (pl) |
ES (1) | ES2913977T3 (pl) |
IL (1) | IL282718B1 (pl) |
PL (1) | PL3860582T3 (pl) |
PT (1) | PT3860582T (pl) |
RS (1) | RS63270B1 (pl) |
SG (1) | SG11202111773QA (pl) |
WO (1) | WO2020152226A1 (pl) |
ZA (1) | ZA202107346B (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3939578A1 (en) * | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7642290B2 (en) | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
EP1750691B1 (en) | 2004-03-26 | 2016-08-10 | Novaremed Ltd. | Compounds for treatment of aids and other diseases |
GB0804213D0 (en) | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
US8802734B2 (en) | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
CN102821761B (zh) | 2009-09-09 | 2015-06-10 | 诺瓦麦有限公司 | 用于治疗疼痛和炎症的n-取代的苯丙酰胺或苯丙烯酰胺 |
GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
WO2013084238A1 (en) | 2011-12-08 | 2013-06-13 | Novaremed Ltd. | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide |
-
2020
- 2020-01-22 CN CN202080010393.8A patent/CN113329746A/zh active Pending
- 2020-01-22 RS RS20220510A patent/RS63270B1/sr unknown
- 2020-01-22 EP EP20703152.7A patent/EP3860582B1/en active Active
- 2020-01-22 AU AU2020210831A patent/AU2020210831A1/en active Pending
- 2020-01-22 CA CA3118996A patent/CA3118996A1/en active Pending
- 2020-01-22 PT PT207031527T patent/PT3860582T/pt unknown
- 2020-01-22 IL IL282718A patent/IL282718B1/en unknown
- 2020-01-22 WO PCT/EP2020/051528 patent/WO2020152226A1/en active Search and Examination
- 2020-01-22 PL PL20703152.7T patent/PL3860582T3/pl unknown
- 2020-01-22 JP JP2021543276A patent/JP2022518288A/ja active Pending
- 2020-01-22 ES ES20703152T patent/ES2913977T3/es active Active
- 2020-01-22 DK DK20703152.7T patent/DK3860582T3/da active
- 2020-01-22 SG SG11202111773QA patent/SG11202111773QA/en unknown
- 2020-01-22 US US17/295,788 patent/US11891350B2/en active Active
- 2020-01-22 KR KR1020217023524A patent/KR20210119403A/ko not_active Application Discontinuation
- 2020-01-22 BR BR112021019476A patent/BR112021019476A2/pt unknown
-
2021
- 2021-09-23 ZA ZA2021/07346A patent/ZA202107346B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US11891350B2 (en) | 2024-02-06 |
BR112021019476A2 (pt) | 2021-11-30 |
AU2020210831A1 (en) | 2021-05-20 |
ZA202107346B (en) | 2023-10-25 |
RS63270B1 (sr) | 2022-06-30 |
WO2020152226A1 (en) | 2020-07-30 |
DK3860582T3 (da) | 2022-05-23 |
SG11202111773QA (en) | 2021-11-29 |
CA3118996A1 (en) | 2020-07-30 |
ES2913977T3 (es) | 2022-06-07 |
KR20210119403A (ko) | 2021-10-05 |
CN113329746A (zh) | 2021-08-31 |
PT3860582T (pt) | 2022-07-08 |
US20220002228A1 (en) | 2022-01-06 |
EP3860582A1 (en) | 2021-08-11 |
IL282718A (en) | 2021-06-30 |
IL282718B1 (en) | 2024-04-01 |
EP3860582B1 (en) | 2022-05-04 |
JP2022518288A (ja) | 2022-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202103977B (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
EP3639833A4 (en) | AGENTS FOR THE PREVENTION OR TREATMENT OF FAT RELATED DISEASES AND INFLAMMATION | |
EP4028021C0 (fr) | Utilisation de nmn pour la prévention et/ou le traitement de la douleur et compositions correspondantes | |
ZA202207493B (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
IL289758A (en) | Proportin inhibitors for use in the prevention and treatment of kidney damage | |
EP3821884A4 (en) | USE OF A COMPOUND IN A MEDICATION FOR THE PREVENTION, TREATMENT OR RELIEF OF PAIN | |
IL282718A (en) | Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases | |
GB201918404D0 (en) | Compounds and their use for the treatment of aplha1-antitrypsin deficiency | |
GB201918413D0 (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
GB201918414D0 (en) | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency | |
IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
IL276228A (en) | Compounds and preparations for the treatment of pain | |
SG10201907677QA (en) | Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases. | |
EP3782627A4 (en) | MEDICINAL PRODUCT USED TO PREVENT AND / OR TREAT PAIN AND / OR FEVER, A COMBINATION PRODUCT, AND USE OF THEM | |
SG11202010906XA (en) | R-fadrozole for use in the treatment of aldostonerism | |
EP3749332A4 (en) | COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ENDOMETRIOSIS AND PAIN | |
GB2574944B (en) | Methods and compositions for the treatment of pain and/or inflammation | |
GB201918539D0 (en) | Compounds for use in treatment and prophylaxis | |
AU2019900258A0 (en) | Pyran compounds and their use in the treatment of pain | |
IL284298A (en) | Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases | |
RS64967B1 (sr) | Kompozicija za upotrebu u prevenciji i/ili lečenju osteoartikularnih bolesti | |
AU2018900504A0 (en) | Methods and compositions for the treatment of pain and/or inflammation | |
GB201918416D0 (en) | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency | |
IL261240B (en) | Preparations useful in the prevention and/or treatment of inflammation and pain | |
SG11202101788VA (en) | Agent for the treatment of skin wounds or burns |